Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough
View ORCID ProfileKevin John Selva, View ORCID ProfilePradhipa Ramanathan, View ORCID ProfileEbene Regina Haycroft, View ORCID ProfileArnold Reynaldi, View ORCID ProfileDeborah Cromer, View ORCID ProfileChee Wah Tan, View ORCID ProfileLin-Fa Wang, View ORCID ProfileBruce D Wines, View ORCID ProfileP Mark Hogarth, View ORCID ProfileLaura E Downie, View ORCID ProfileSamantha K Davis, View ORCID ProfileRuth Amy Purcell, Helen E Kent, View ORCID ProfileJennifer A Juno, View ORCID ProfileAdam K Wheatley, View ORCID ProfileMiles P Davenport, View ORCID ProfileStephen John Kent, View ORCID ProfileAmy W Chung
doi: https://doi.org/10.1101/2023.03.28.23287848
Kevin John Selva
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Pradhipa Ramanathan
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Ebene Regina Haycroft
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Arnold Reynaldi
2Kirby Institute, University of New South Wales, Kensington, New South Wales, 2052, Australia
Deborah Cromer
2Kirby Institute, University of New South Wales, Kensington, New South Wales, 2052, Australia
Chee Wah Tan
3Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore
Lin-Fa Wang
3Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore
4Singhealth Duke-NUS Global Health Institute, 169856, Singapore
Bruce D Wines
5Immune Therapies Laboratory, Burnet Institute, Melbourne, Victoria, 3004 Australia
6Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, 3800, Australia
7Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, 3000, Australia
P Mark Hogarth
5Immune Therapies Laboratory, Burnet Institute, Melbourne, Victoria, 3004 Australia
6Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria, 3800, Australia
7Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, 3000, Australia
Laura E Downie
8Department of Optometry and Vision Sciences, University of Melbourne, Carlton, Victoria, 3053, Australia
Samantha K Davis
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Ruth Amy Purcell
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Helen E Kent
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Jennifer A Juno
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Adam K Wheatley
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Miles P Davenport
2Kirby Institute, University of New South Wales, Kensington, New South Wales, 2052, Australia
Stephen John Kent
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
9Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia
Amy W Chung
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, 3000, Australia
Posted March 30, 2023.
Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough
Kevin John Selva, Pradhipa Ramanathan, Ebene Regina Haycroft, Arnold Reynaldi, Deborah Cromer, Chee Wah Tan, Lin-Fa Wang, Bruce D Wines, P Mark Hogarth, Laura E Downie, Samantha K Davis, Ruth Amy Purcell, Helen E Kent, Jennifer A Juno, Adam K Wheatley, Miles P Davenport, Stephen John Kent, Amy W Chung
medRxiv 2023.03.28.23287848; doi: https://doi.org/10.1101/2023.03.28.23287848
Lasting first impression: Pre-existing immunity restricts mucosal antibody responses during Omicron breakthrough
Kevin John Selva, Pradhipa Ramanathan, Ebene Regina Haycroft, Arnold Reynaldi, Deborah Cromer, Chee Wah Tan, Lin-Fa Wang, Bruce D Wines, P Mark Hogarth, Laura E Downie, Samantha K Davis, Ruth Amy Purcell, Helen E Kent, Jennifer A Juno, Adam K Wheatley, Miles P Davenport, Stephen John Kent, Amy W Chung
medRxiv 2023.03.28.23287848; doi: https://doi.org/10.1101/2023.03.28.23287848
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)